Once-monthly paliperidone palmitate in early stage schizophrenia – a retrospective, non-interventional 1-year study of patients with newly diagnosed schizophrenia

BACKGROUND: Long-acting antipsychotic therapy may be best suited for patients in the early stage of schizophrenia, when the most can be done before disease progression associated with poor adherence occurs. We explored the patterns of use of once-monthly paliperidone palmitate (PP1M), concomitant me...

Descripción completa

Detalles Bibliográficos
Autores principales: Emsley, Robin, Hargarter, Ludger, Bergmans, Paul, Uglešić, Boran, Sengül, Abdullah Cem, Petralia, Antonino, Khannanova, Angelina, Cherubin, Pierre, Schreiner, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587220/
https://www.ncbi.nlm.nih.gov/pubmed/28919757
http://dx.doi.org/10.2147/NDT.S142634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587220/
https://www.ncbi.nlm.nih.gov/pubmed/28919757
http://dx.doi.org/10.2147/NDT.S142634

Ejemplares similares